[1]
Lebwohl, M., Warren, R.B., Sofen, H., Imafuku, S., Paul, C., Szepietowski, J.C., Spelman, L., Passeron, T., Colston, E., Hippeli, L., Napoli, A., Kisa, R.M., Banerjee, S., Menter, A., Thaçi, D. and Blauvelt, A. 2023. Deucravacitinib long-term efficacy with continuous treatment in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s118. DOI:https://doi.org/10.25251/skin.7.supp.118.